The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Summit Therapeutics Inc(NASDAQ:SMMT) 
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States, Latin America, and Europe. It conducts clinical programs focusing on the Clostridioides difficile infection (CDI). The company's lead product ca...
Website: http://www.summitplc.com
Founded: 2003
Full Time Employees: 70
Sector: Healthcare
Industry: Biotechnology
Summit Therapeutics Days Payable Outstanding ttm (DPO)
Summit Therapeutics Days Receivable Outstanding ttm (DSO)
Summit Therapeutics Days Inventory Outstanding ttm (DIO)
Summit Therapeutics Op Cashflow Per Share ttm
Summit Therapeutics Free Cashflow Per Share ttm
Summit Therapeutics Cash Per Share ttm
Summit Therapeutics P/S ratio ttm
Summit Therapeutics (GAAP) P/E ratio ttm
Summit Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.